MetLife Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.37M | Hold |
|
|||||
|
2025
Q2 | $936K | Buy |
|
|||||
|
2025
Q1 | $1.15M | Sell |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $707K | Hold |
|
|||||
|
2024
Q2 | $584K | Buy |
|
|||||
|
2024
Q1 | $565K | Hold |
|
|||||
|
2023
Q4 | $315K | Buy |
|
|||||
|
2023
Q3 | $227K | Hold |
|
|||||
|
2023
Q2 | $231K | Buy |
|
|||||
|
2023
Q1 | $134K | Hold |
|
|||||
|
2022
Q4 | $156K | Hold |
|
|||||
|
2022
Q3 | $183K | Hold |
|
|||||
|
2022
Q2 | $156K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $134K | Buy |
|